Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
LifeSave.org
it exists in two primary states: reduced and oxidized
CJC-1295 + Ipamorelin is a USA-manufactured dual-peptide GH axis research blend combining CJC-1295 No DAC (ModGRF 1-29) a synthetic GHRH analogue that activates the GHRH receptor on anterior pituitary somatotrophs via Gs-cAMP signaling and Ipamorelin, a selective GH secretagogue that activates the ghrelin receptor (GHS-R1a) via the distinct Gq/11 intracellular pathway, providing simultaneous dual-receptor GH axis stimulation in a single research preparation
:max_bytes(150000):strip_icc()/Health-GettyImages-2148794378-e9772f0b14a24b199dd96bab8f722ea9.jpg)
Texte intgral : 11
Created to combat obesity and diabetes, GLP-1 agonists are now being assessed in dozens of disorders
As GLP-1 medications continue to expand beyond diabetes treatment and become increasingly common for weight management, Kaestner believes more research will be needed to understand whether their broader social effects become more apparent in other populations or over longer periods of time
US$ 24.89
US$ 29.45
US$ 25.44
